Neurological dysfunction is not uncommon in patients suffering from acquired immunodeficiency syndrome (AIDS) and, when manifested, intimates involvement of the central nervous system. Here, the human immunodeficiency virus (HIV) infects preferentially microglial cells, which thereby release substances known to interfere with neuronal function. One class of agents set free in this manner are proteases; these degrade certain components within, and thereby undermine the integrity of, the extracellular matrix (ECM) compartment, which plays a vital role in cell-to-cell communication. We wished to ascertain whether the ECM compartment is indeed disrupted in the brains of AIDS victims. We examined the neocortical areas of 27 AIDS autopsy cases, including 9 with diagnosed HIVencephalopathy (HIVE); 8 HIV-seronegative cases with various types of brain lesion, including viral infections, were also included in this study. HIV-antigens and DNA were identified by use of immunohistochemistry and in situ hybridization, and ECM components by lectin staining and immunohistochemistry. Of the 27 AIDS cases examined, each of the 9 with HIVE was completely devoid of labeled ECM components; 8 of the 18 without HIVE had incurred substantial losses, and only 2 manifested a normal complement of constituents within this compartment. With respect to stratal and topographic variations, layers II and III were less affected than layers V to VII, as was the frontal cortex relative to other areas. These findings confirmed our expectations of the brain's ECM undergoing degradation following HIV infection, and these changes may well underlie the neurological disturbances manifested in AIDS patients. 1997 Academic Press
INTRODUCTION
Most patients suffering from AIDS 1 evince signs of CNS involvement during the terminal stages of this disease (Lang et al., 1989; Glass et al., 1993; Rhodes, 1994) . The neurological disturbances manifested range from moderate impairment of coordination (HIVassociated cognitive/motor complex) to complete dementia [(also referred to as AIDS-dementia complex or HIV-1-associated dementia) Navia et al., 1986 ; Working Group of the American Academy of Neurology AIDS Task Force, 1991] . In the vast majority of such cases, the CNS is affected by viral or nonviral opportunistic infections, secondary to the acquired immunodeficiency syndrome (Lang et al., 1989) . About 16% of AIDS patients develop HIVE, this being attributable to direct infection of the CNS with HIV-1 (Navia et al., 1986; Lang et al., 1989) . In vitro, HIV-1 exhibits a preferential tropism for microglia (Watkins et al., 1990;  for review see Dickson & Lee, 1996) , and viral antigens, such as gp41, can be detected immunohistochemically in these cells as well as in the multinucleated giant ones which they induce (Wiley et al., 1986; Vazeux et al., 1987; Price et al., 1988; Masliah et al., 1992a) . There is increasing evidence that astrocytes (Erfle et al., 1992) , oligodendrocytes, and vascular endothelial cells may also become infected with HIV-1, but in these in-
